의료용 플라스틱 시장 보고서 : 동향, 예측 및 경쟁 분석(-2035년)

Medical Plastics Market

The future of the global medical plastics market looks promising with opportunities in the medical device packaging, medical component, orthopedic implant packaging, orthopedic soft good, wound care, cleanroom supplies, biopharm device, and mobility aids markets. The global medical plastics market is expected to reach an estimated $42.9 billion by 2035 from $30.4 billion in 2027 with a CAGR of 5.1% from 2027 to 2035. The major drivers for this market are growing demand for advanced medical technology and devices, rising healthcare investments in the developing countries, and increasing inclination towards minimally invasive medical procedures.

• Lucintel forecasts that, within the product category, polyphenylsulfone (PES) will remain the largest segment over the forecast period because it ensures good heat and chemical resistance thus making it ideal for the replacement of metals in medical applications.
• Within the application category, medical components will remain the largest segment due to the growing usage of PP in the manufacturing of diagnostic devices, trays, pans, containers, syringes, implant trials, and medical cover sheets.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the robust digitization in the healthcare ecosystem and increasing awareness towards medical plastics.

Emerging Trends in Medical Plastics Market

New trends in the medical plastics market create unique opportunities to integrate new concepts which cater to modern healthcare needs.

• Environmentally Adaptive Plastics: With sustainability in mind, some plastics decompose rapidly and are being designed for use as single-use products and packaging for medical products.
• Safer Plastics: Lack of biocompatibility and reactivity of traditional plastics has inspired development of new biomaterials. These biomaterials are safe for use in implantable and contact devices.
• Interactive Plastics: Integration of new technologies into plastics is emerging. Plastics that can sense and respond to their environment are being used to create technologies that allow real time monitoring and control of medical technologies.
• Personalized Medical Plastics: Advances in plastics manufacturing have enabled drivers of innovation in medical plastics. 3D printing has revolutionized the manufacturing of medical technologies by enabling both customized and exact designs for medical implants and prosthetics.
• Stringent Regulations: Novel technologies have encouraged stricter regulations for medical plastics. These regulations ensure quality and safety, particularly on implants that come into contact with the body for a prolonged period and on systems for delivering drugs.

Higher demand is leading to faster innovation in high-performing, safe, and eco-friendly materials. Regulations and sustainability goals set by the medical plastics market are driving these changes.

Recent Developments in the Medical Plastics Market

New trends in the medical plastics market create unique opportunities to integrate new concepts which cater to modern healthcare needs.

• Environmentally Adaptive Plastics: With sustainability in mind, some plastics decompose rapidly and are being designed for use as single-use products and packaging for medical products.
• Safer Plastics: Lack of biocompatibility and reactivity of traditional plastics has inspired development of new biomaterials. These biomaterials are safe for use in implantable and contact devices.
• Interactive Plastics: Integration of new technologies into plastics is emerging. Plastics that can sense and respond to their environment are being used to create technologies that allow real time monitoring and control of medical technologies.
• Personalized Medical Plastics: Advances in plastics manufacturing have enabled drivers of innovation in medical plastics. 3D printing has revolutionized the manufacturing of medical technologies by enabling both customized and exact designs for medical implants and prosthetics.
• Stringent Regulations: Novel technologies have encouraged stricter regulations for medical plastics. These regulations ensure quality and safety, particularly on implants that come into contact with the body for a prolonged period and on systems for delivering drugs.

Higher demand is leading to faster innovation in high-performing, safe, and eco-friendly materials. Regulations and sustainability goals set by the medical plastics market are driving these changes.

Strategic Growth Opportunities in the Medical Plastics Market

Opportunities for strategic growth exist in the medical plastics market due to rapid technological advancements and broadening market applications.

• High Growth Potential with Disposable Medical Devices: High-performance plastics used in disposable medical devices create new business opportunities. Value opportunities exist for creating medical devices such as syringes and catheters using low cost, high performance plastics that are single use.
• Innovation Potential with Implantable Devices: High growth potential exists with the advancement of innovative high performance plastics used with implantable medical devices and orthopedic and cardiovascular implants. innovation focus is on advanced plastics that are biocompatible and more durable for better patient outcomes.
• Innovation Potential with Diagnostic Equipment: Growth and development of advanced medical plastics is occurring with diagnostic equipment and systems. Innovation with the development of more precise, durable plastics is a new business opportunity in this market.
• Innovation with Drug Delivery Devices: Medical plastics play a key role in the innovation with drug delivery devices focused on the safety and the efficiency and control of drug delivery.
• Innovation with Sustainable Packaging: New business opportunities exist in sustainable medical plastics used for packaging and designing packaging systems with biowaste plastics.

The diversity of opportunities shaping the medical plastics market are demonstrating rapid innovation of existing applications, demands for sustainability along with the reduction of costs.

Medical Plastics Market Drivers and Challenges

There are several growth and development factors as well as limitations for the medical plastics market.

Driving forces behind the market expansion for Medical Plastics are:

1. Development of Technologies: Advancement of plastic technologies involving smart and biodegradable plastics are developing the market. Smart plastics address the market's needs for environmentally safe products to develop healthcare-related products. Biodegradable plastics are also increasingly used in healthcare.

2. Increasing Healthcare Needs: With an aging population and more demand for healthcare, there is a greater need for medical devices and diagnostics. Used in combination with high-performance plastics, this creates greater demand for advanced medical plastics.

3. Investments in R&D: High levels of funding for R&D generate new medical plastics with more advanced characteristics. It helps the R&D process and creates possibilities for newer advanced medical plastics.

4. Regulations: Medical plastics are supported by regulations and standards. Regulations drive market development and encourage medical plastics innovations and advancements.

5. Focus on Sustainability: New plastics are becoming more environmentally safe and friendlier to healthcare sustainability, limited plastics use and environmentally friendly practices.

Challenges for the medical plastics market are:

1. High Costs of Production: Advanced medical plastics are increasingly expensive and can limit market growth. Some users, especially price-sensitive buyers, can be excluded from the market.

2. Regulatory Compliance: Meeting demanding regulatory standards during the manufacturing process will inherently drive up the costs to the producer and impede innovation throughout the industry.

3. Environmental Impact: The production and disposal of plastic negatively impacts the environment and is a problem we have yet to solve. Medical plastics must be effective and efficient, and are better for the environment.

The above mentioned trends and hurdles affect the dynamics of investment and innovation within the medical plastics industry.

List of Medical Plastics Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies medical plastics market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the medical plastics market companies profiled in this report include-

• Rochling
• Nolato
• Saint-Gobain
• SABIC
• Orthoplastics
• Eastman Chemical
• Celanese Corporation
• Dow
• Tekni-Plex
• Solvay

Medical Plastics Market by Segment

The study includes a forecast for the global medical plastics by product, application, and region

Medical Plastics Market by Product [Value ($B) from 2019 to 2035]:

• Polyethylene (PE)
• Polypropylene (PP)
• Polycarbonate (PC)
• Liquid Crystal Polymer (LCP)
• Polyphenylsulfone (PPSU)
• Polyethersulfone (PES)
• Polyethylenimine (PEI)
• Polymethyl Methacrylate (PMMA)
• Others

Medical Plastics Market by Application [Value ($B) from 2019 to 2035]:

• Medical Device Packaging
• Medical Components
• Orthopedic Implant Packaging
• Orthopedic Soft Goods
• Wound Care
• Cleanroom Supplies
• BioPharm Devices
• Mobility Aids
• Others

Medical Plastics Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Medical Plastics Market

Advancements in medical plastics technologies and subsequent market maturation can be attributed to increasing demands and innovations in the healthcare industry. This in turn is leading to an adoption of plastics in the medical industry across regions.

• United States: Implant and diagnostic kits developers in the U.S. are using implant grade biocompatible and high performance plastics in order to create plastics that are safer and improve the shelf life of plastics while reducing the potential for infection.
• China: Medical plastics are increasingly used in China and local manufacturing capacity is improving along with the quality of plastics used in medical devices. Safety and performance laws are also being improved.
• Germany: New products that comply with stricter laws and regulations within the European Union are being manufactured. These include biodegradable plastics and higher quality medical grade plastic manufactures.
• India: New medical plastics technologies geared towards energy efficient and low cost manufacture are being pursued. Innovations in plastic manufacturing provide improved health care options through disposable products supplied through local manufacture.
• Japan: Japan is the leader in utilizing newer polymer technologies that provide a combination of strength, flexibility, low weight, and high impact in order to transform a broad range of medical equipment, from implantation to diagnostic devices, for both first-time use and repeated use.

Features of the Global Medical Plastics Market

• Market Size Estimates: medical plastics market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecasts (2024 to 2030) by various segments and regions.
• Segmentation Analysis: medical plastics market size by product, application, and region in terms of value ($B).
• Regional Analysis: medical plastics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different product, application and regions for the medical plastics market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the medical plastics market

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the medical plastics market by product (polyethylene (PE), polypropylene (PP), polycarbonate (PC), liquid crystal polymer (LCP), polyphenylsulfone (PPSU), polyethersulfone (PES), polyethylenimine (PEI), polymethyl methacrylate (PMMA), and others), application (medical device packaging, medical components, orthopedic implant packaging, orthopedic soft goods, wound care, cleanroom supplies, biopharm devices, mobility aids, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Medical Plastics Market by Product

• 4.1 Overview
• 4.2 Attractiveness Analysis by Product
• 4.3 Polyethylene (PE): Trends and Forecast (2019-2035)
• 4.4 Polypropylene (PP): Trends and Forecast (2019-2035)
• 4.5 Polycarbonate (PC): Trends and Forecast (2019-2035)
• 4.6 Liquid Crystal Polymer (LCP): Trends and Forecast (2019-2035)
• 4.7 Polyphenylsulfone (PPSU): Trends and Forecast (2019-2035)
• 4.8 Polyethersulfone (PES): Trends and Forecast (2019-2035)
• 4.9 Polyethylenimine (PEI): Trends and Forecast (2019-2035)
• 4.10 Polymethyl Methacrylate (PMMA): Trends and Forecast (2019-2035)
• 4.11 Others: Trends and Forecast (2019-2035)

5. Global Medical Plastics Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Medical Device Packaging: Trends and Forecast (2019-2035)
• 5.4 Medical Components: Trends and Forecast (2019-2035)
• 5.5 Orthopedic Implant Packaging: Trends and Forecast (2019-2035)
• 5.6 Orthopedic Soft Goods: Trends and Forecast (2019-2035)
• 5.7 Wound Care: Trends and Forecast (2019-2035)
• 5.8 Cleanroom Supplies: Trends and Forecast (2019-2035)
• 5.9 BioPharm Devices: Trends and Forecast (2019-2035)
• 5.10 Mobility Aids: Trends and Forecast (2019-2035)
• 5.11 Others: Trends and Forecast (2019-2035)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Medical Plastics Market by Region

7. North American Medical Plastics Market

• 7.1 Overview
• 7.2 North American Medical Plastics Market by Product
• 7.3 North American Medical Plastics Market by Application
• 7.4 United States Medical Plastics Market
• 7.5 Mexican Medical Plastics Market
• 7.6 Canadian Medical Plastics Market

8. European Medical Plastics Market

• 8.1 Overview
• 8.2 European Medical Plastics Market by Product
• 8.3 European Medical Plastics Market by Application
• 8.4 German Medical Plastics Market
• 8.5 French Medical Plastics Market
• 8.6 Spanish Medical Plastics Market
• 8.7 Italian Medical Plastics Market
• 8.8 United Kingdom Medical Plastics Market

9. APAC Medical Plastics Market

• 9.1 Overview
• 9.2 APAC Medical Plastics Market by Product
• 9.3 APAC Medical Plastics Market by Application
• 9.4 Japanese Medical Plastics Market
• 9.5 Indian Medical Plastics Market
• 9.6 Chinese Medical Plastics Market
• 9.7 South Korean Medical Plastics Market
• 9.8 Indonesian Medical Plastics Market

10. ROW Medical Plastics Market

• 10.1 Overview
• 10.2 ROW Medical Plastics Market by Product
• 10.3 ROW Medical Plastics Market by Application
• 10.4 Middle Eastern Medical Plastics Market
• 10.5 South American Medical Plastics Market
• 10.6 African Medical Plastics Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Product
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Medical Plastics Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Rochling
  • Company Overview
  • Medical Plastics Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Nolato
  • Company Overview
  • Medical Plastics Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Saint-Gobain
  • Company Overview
  • Medical Plastics Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 SABIC
  • Company Overview
  • Medical Plastics Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Orthoplastics
  • Company Overview
  • Medical Plastics Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Eastman Chemical
  • Company Overview
  • Medical Plastics Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Celanese Corporation
  • Company Overview
  • Medical Plastics Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Dow
  • Company Overview
  • Medical Plastics Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Tekni-Plex
  • Company Overview
  • Medical Plastics Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Solvay
  • Company Overview
  • Medical Plastics Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us